Msi1 inhibits cervical cancer cell apoptosis by downregulating BAK through AKT signaling

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Musashi-1 (Msi1) is an RNA-binding protein implicated in various carcinomas.
• Msi1 promotes cervical cancer cell proliferation by affecting cell cycle proteins (P21, P27, P53).
• Mechanisms of Msi1's impact on cervical cancer cell survival, particularly apoptosis, remain largely unknown.

Purpose of the Study:

• To investigate the role of Musashi-1 (Msi1) in regulating apoptosis of cervical cancer cells.
• To elucidate the molecular pathways through which Msi1 influences cervical cancer cell survival.

Main Methods:

• In vitro and in vivo experiments assessing apoptosis in cervical cancer cells with varying Msi1 expression.
• Analysis of PTEN, AKT signaling pathway, and BAK protein expression levels.
• Rescue experiments involving BAK expression restoration in Msi1-expressing cells.

Main Results:

• Msi1 expression significantly inhibited apoptosis in cervical cancer cells, both in vitro and in vivo.
• Msi1 downregulated PTEN expression, leading to AKT signaling activation.
• AKT activation resulted in decreased levels of the proapoptotic protein BAK.
• Restoring BAK expression in Msi1-expressing cells increased apoptosis.

Conclusions:

• Musashi-1 (Msi1) regulates cervical cancer cell apoptosis through the PTEN/AKT signaling pathway.
• Msi1 inhibits apoptosis by downregulating PTEN, activating AKT, and subsequently reducing BAK levels.
• Targeting the Msi1-PTEN-AKT-BAK axis may offer therapeutic strategies for cervical cancer.